[1]
|
Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses
Diabetes,
2024
DOI:10.2337/db23-0564
|
|
|
[2]
|
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression
Cancer Letters,
2024
DOI:10.1016/j.canlet.2024.217009
|
|
|
[3]
|
TGFBI: A novel therapeutic target for cancer
International Immunopharmacology,
2024
DOI:10.1016/j.intimp.2024.112180
|
|
|
[4]
|
FN1 and TGFBI are key biomarkers of macrophage immune injury in diabetic kidney disease
Medicine,
2023
DOI:10.1097/MD.0000000000035794
|
|
|
[5]
|
Astragalus polysaccharides protect renal function and affect the TGF-β/Smad signaling pathway in streptozotocin-induced diabetic rats
Journal of International Medical Research,
2020
DOI:10.1177/0300060520903612
|
|
|
[6]
|
Guided assembly, nanostructuring and functionalization with brushes of microscale polymer cubes for tailored 3-D cell microenvironments
European Polymer Journal,
2019
DOI:10.1016/j.eurpolymj.2019.01.031
|
|
|
[7]
|
Impaired Autophagic Degradation of Transforming Growth Factor-β-Induced Protein by Macrophages in Lattice Corneal Dystrophy
Investigative Opthalmology & Visual Science,
2019
DOI:10.1167/iovs.18-25838
|
|
|
[8]
|
Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy
Frontiers in Medicine,
2017
DOI:10.3389/fmed.2017.00102
|
|
|
[9]
|
TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy
Eye,
2016
DOI:10.1038/eye.2016.179
|
|
|
[10]
|
BIGH3: A Negative Regulator of Human Osteosarcoma Large Multicellular Spheroids
International Journal of Clinical Medicine,
2016
DOI:10.4236/ijcm.2016.711084
|
|
|